摘要 |
New spiro[4.5]decane derivatives which can be used as a medicament and correspond to the formula: …<IMAGE>… in which X, A, Y, T, Z, R1, R2, R3, R4, R5 and R6 are as defined in the description. …<??>These derivatives and their physiologically tolerable salts may be used in therapy, in particular in the treatment of dyslipidaemias, atherosclerosis and pathologies in which membrane lipid peroxidation plays a part in initiation and/or aggravation. |